Search Within

Gastrointestinal Oncology Service

  1. "Hepatology"
Formats
  1. Meeting Abstract (10)
  2. Journal Article (5)
Groups
  1. Department of Medicine (15)
  2. Solid Tumor Oncology Division (15)
  3. Biostatistics Service (1)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (1)
  5. Center for Pancreatic Cancer Research (1)
  6. Computational Oncology Service (1)

More Groups

People
  1. Ghassan Abou-Alfa (14)
  2. James Harding (3)
  3. Andrea Cercek Hanjis (1)
  4. Bastien Nguyen (1)
  5. Carlie Sigel (1)
  6. David Solit (1)

More People

Years
  1. 2025 (2)
  2. 2024 (3)
  3. 2023 (1)
  4. 2022 (2)
  5. 2021 (3)
  6. 2019 (1)

More Years

Publications
  1. Hepatology (15)
Publishers
  1. John Wiley & Sons (15)

Results (15)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Comparative effectiveness of immunotherapy versus lenvatinib in advanced hepatocellular carcinoma: A real-world analysis using target trial emulation
    Journal Article

    Ahn, J. C.; Ng, W. H.; Yeo, Y. H.; Kim, H. S.; Wang, Y.; Trivedi, H.; Ayoub, W. S.; Kuo, A.; Rich, N.; Parikh, N. D.; more...
    Hepatology (2025)

    Fulltext@MSK | Save
  • Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable hepatocellular carcinoma: HIMALAYA Phase 3 randomized clinical trial
    Journal Article

    Lau, G.; Sangro, B.; Cheng, A. L.; Kudo, M.; Kelley, R. K.; Tak, W. Y.; Gasbarrini, A.; Reig, M.; Lim, H. Y.; Tougeron, D.; more...
    Hepatology (2025)

    Fulltext@MSK | Save
  • Outcomes by comorbidities with tremelimumab and durvalumab in the phase 3 Himalaya study in unresectable hepatocellular carcinoma
    Meeting Abstract

    Rimassa, L.; Dayyani, F.; Kelley, R. K.; Sangro, B.; Chan, S. L.; McCoy, C. L.; Paskow, M. J.; Makowsky, M.; Gupta, C.; Ran, D.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Non-viral etiology subgroup of the phase 3 Himalaya study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Reig, M.; Tam, V.; Sangro, B.; Archambeaud, I.; Kelley, R. K.; Chan, S.; Kudo, M.; Masi, G.; Paskow, M.; Makowsky, M.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Five-year overall survival and overall survival by tumor response measures from the phase 3 Himalaya study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Rimassa, L.; Chan, S.; Sangro, B.; Lau, G.; Kudo, M.; Breder, V.; Varela, M.; Crysler, O.; Bouattour, M.; Dao, T. V.; more...
    Hepatology (2024)

    Fulltext@MSK | Save
  • Four-year overall survival update from the phase 3 HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
    Meeting Abstract

    Abou-Alfa, G. K.; Chan, S. L.; Kelley, K.; Lau, G.; Kudo, M.; Sukeepaisarnjaroen, W.; De Toni, E. N.; Furuse, J.; Kang, Y. K.; Galle, P. R.; more...
    Hepatology (2023)

    Fulltext@MSK | Save
  • Outcomes by baseline liver function in patients with unresectable hepatocellular carcinoma treated with tremelimumab and durvalumab in the phase 3 HIMALAYA study
    Meeting Abstract

    Vogel, A.; Chan, S. L.; Furuse, J.; Tak, W. Y.; Masi, G.; Varela, M.; Kim, J. H.; Tanasanvimon, S.; Reig, M.; Dayyani, F.; more...
    Hepatology (2022)

    Fulltext@MSK | Save
  • Racial and ethnic disparities in early treatment with immunotherapy for advanced HCC in the United States
    Journal Article

    Ahn, J. C.; Lauzon, M.; Luu, M.; Noureddin, M.; Ayoub, W.; Kuo, A.; Sundaram, V.; Kosari, K.; Nissen, N.; Gong, J.; more...
    Hepatology (2022)

    Fulltext@MSK | Save
  • A multi-analyte blood test for accurate and early detection of hepatocellular carcinoma
    Meeting Abstract

    Lin, N.; Lin, Y.; Xu, J.; Li, M.; Liu, D.; Gallant, M. A.; Kubota, N.; Roy, D.; Li, J.; Gorospe, E. C.; more...
    Hepatology (2021)

    Fulltext@MSK | Save
  • First-in-human effects of PPT1 inhibition using the oral GNS561 in patients with primary and secondary liver malignancies
    Meeting Abstract

    Harding, J. J.; Awada, A.; Decaens, T.; Roth, G.; Merle, P.; Kotecki, N.; Dreyer, C.; Ansaldi, C.; Rachid, M.; Mezouar, S.; more...
    Hepatology (2021)

    Fulltext@MSK | Save